Clinical Trial of AMG510 in Stage III Unresectable NSCLC KRAS p.G12C Patients and Ineligible for Chemo-radiotherapy

Clinical trial NCT05398094 · RECRUITING

Trial details

NCT number: NCT05398094
Sponsor: Fundación GECP
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer Stage III KRAS P.G12C

Start date: 2022-03-21
Primary completion: 2027-12-31
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.